Iatrogenic Cushing Syndrome Secondary to a Probable Interaction Between Voriconazole and Budesonide.
- Published in:
- Pharmacotherapy, 2014, v. 34, n. 7, p. e116, doi. 10.1002/phar.1432
- By:
- Publication type:
- Article
Works matching IS 02770008 AND DT 2014 AND VI 34 AND IP 7
Results: 14
1
2
Patterns of Antibacterial Use and Impact of Age, Race/Ethnicity, and Geographic Region on Antibacterial Use in an Outpatient Medicaid Cohort.
- Published in:
- Pharmacotherapy, 2014, v. 34, n. 7, p. 677, doi. 10.1002/phar.1425
- By:
- Publication type:
- Article
3
Use of a Pharmacy Protocol to Convert Standard Rituximab Infusions to Rapid Infusion Shortens Outpatient Infusion Clinic Visits.
- Published in:
- Pharmacotherapy, 2014, v. 34, n. 7, p. 686, doi. 10.1002/phar.1420
- By:
- Publication type:
- Article
4
Comparison of the Incidence of Vancomycin-Induced Nephrotoxicity in Hospitalized Patients with and without Concomitant Piperacillin-Tazobactam.
- Published in:
- Pharmacotherapy, 2014, v. 34, n. 7, p. 670, doi. 10.1002/phar.1442
- By:
- Publication type:
- Article
5
'Not for Human Consumption': A Review of Emerging Designer Drugs.
- Published in:
- Pharmacotherapy, 2014, v. 34, n. 7, p. 745, doi. 10.1002/phar.1424
- By:
- Publication type:
- Article
6
High Incidence of Discontinuations Due to Adverse Events in Patients Treated with Ceftaroline.
- Published in:
- Pharmacotherapy, 2014, v. 34, n. 7, p. 758, doi. 10.1002/phar.1435
- By:
- Publication type:
- Article
7
Comparison of Acute Kidney Injury During Treatment with Vancomycin in Combination with Piperacillin-Tazobactam or Cefepime.
- Published in:
- Pharmacotherapy, 2014, v. 34, n. 7, p. 662, doi. 10.1002/phar.1428
- By:
- Publication type:
- Article
8
Increased Levetiracetam Clearance Associated with a Breakthrough Seizure in a Pregnant Patient Receiving Once/Day Extended-Release Levetiracetam.
- Published in:
- Pharmacotherapy, 2014, v. 34, n. 7, p. e128, doi. 10.1002/phar.1439
- By:
- Publication type:
- Article
9
Distinguishing Anemia and Iron Deficiency of Heart Failure: Signal for Severity of Disease or Unmet Therapeutic Need?
- Published in:
- Pharmacotherapy, 2014, v. 34, n. 7, p. 719, doi. 10.1002/phar.1412
- By:
- Publication type:
- Article
10
Vancomycin-Associated Nephrotoxicity in Adult Medicine Patients: Incidence, Outcomes, and Risk Factors.
- Published in:
- Pharmacotherapy, 2014, v. 34, n. 7, p. 653, doi. 10.1002/phar.1423
- By:
- Publication type:
- Article
11
Evaluation of Warfarin Dose Requirements in Patients with Chronic Kidney Disease and End-Stage Renal Disease.
- Published in:
- Pharmacotherapy, 2014, v. 34, n. 7, p. 695, doi. 10.1002/phar.1445
- By:
- Publication type:
- Article
12
CYP2C19 Polymorphisms and Therapeutic Drug Monitoring of Voriconazole: Are We Ready for Clinical Implementation of Pharmacogenomics?
- Published in:
- Pharmacotherapy, 2014, v. 34, n. 7, p. 703, doi. 10.1002/phar.1400
- By:
- Publication type:
- Article
13
Antifungal Catheter Lock Therapy for the Management of a Persistent Candida albicans Bloodstream Infection in an Adult Receiving Hemodialysis.
- Published in:
- Pharmacotherapy, 2014, v. 34, n. 7, p. e120, doi. 10.1002/phar.1433
- By:
- Publication type:
- Article
14
Antibody-Mediated Rejection in Kidney Transplantation: A Review of Pathophysiology, Diagnosis, and Treatment Options.
- Published in:
- Pharmacotherapy, 2014, v. 34, n. 7, p. 733, doi. 10.1002/phar.1426
- By:
- Publication type:
- Article